The estimated Net Worth of Edward Hurwitz is at least $17 Milion dollars as of 20 May 2024. Edward Hurwitz owns over 4,500 units of Dyne Therapeutics stock worth over $1,224,912 and over the last 16 years Edward sold DYN stock worth over $15,747,977.
Edward has made over 4 trades of the Dyne Therapeutics stock since 2009, according to the Form 4 filled with the SEC. Most recently Edward exercised 4,500 units of DYN stock worth $146,700 on 20 May 2024.
The largest trade Edward's ever made was selling 2,232,464 units of Dyne Therapeutics stock on 14 December 2009 worth over $4,487,253. On average, Edward trades about 58,193 units every 120 days since 2009. As of 20 May 2024 Edward still owns at least 37,574 units of Dyne Therapeutics stock.
You can see the complete history of Edward Hurwitz stock trades at the bottom of the page.
Edward's mailing address filed with the SEC is 1560 TRAPELO ROAD, , WALTHAM, MA, 02451.
Over the last 4 years, insiders at Dyne Therapeutics have traded over $197,573,300 worth of Dyne Therapeutics stock and bought 5,790,447 units worth $92,382,301 . The most active insiders traders include Capital Management, L.P.Kol..., Jason P Rhodes oraz Dirk Kersten. On average, Dyne Therapeutics executives and independent directors trade stock every 12 days with the average trade being worth of $3,566,016. The most recent stock trade was executed by Oxana Beskrovnaya on 11 September 2024, trading 2,161 units of DYN stock currently worth $68,914.
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..
Dyne Therapeutics executives and other stock owners filed with the SEC include: